171.39
price down icon1.47%   -2.2883
 
loading
Quest Diagnostics Inc stock is traded at $171.39, with a volume of 336.98K. It is down -1.47% in the last 24 hours and down -3.15% over the past month. Quest Diagnostics Inc is a leading independent provider of diagnostic testing, information, and services in the us. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
See More
Previous Close:
$173.68
Open:
$172.91
24h Volume:
336.98K
Relative Volume:
0.26
Market Cap:
$19.12B
Revenue:
$9.54B
Net Income/Loss:
$841.00M
P/E Ratio:
23.04
EPS:
7.44
Net Cash Flow:
$1.02B
1W Performance:
+0.38%
1M Performance:
-3.15%
6M Performance:
+4.78%
1Y Performance:
+23.19%
1-Day Range:
Value
$171.04
$173.67
1-Week Range:
Value
$168.46
$173.95
52-Week Range:
Value
$135.47
$179.99

Quest Diagnostics Inc Stock (DGX) Company Profile

Name
Name
Quest Diagnostics Inc
Name
Phone
(973) 520-2700
Name
Address
500 PLAZA DRIVE, SECAUCUS
Name
Employee
56,000
Name
Twitter
@QuestDX
Name
Next Earnings Date
2025-04-22
Name
Latest SEC Filings
Name
DGX's Discussions on Twitter

Compare DGX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Diagnostics & Research icon
DGX
Quest Diagnostics Inc
171.26 19.90B 9.54B 841.00M 1.02B 7.44
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
402.62 156.19B 42.90B 6.52B 6.72B 17.05
Diagnostics & Research icon
DHR
Danaher Corp
189.99 141.54B 23.82B 3.77B 4.90B 5.15
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
515.28 41.59B 3.93B 894.97M 837.70M 10.82
Diagnostics & Research icon
A
Agilent Technologies Inc
111.34 32.35B 6.53B 1.26B 1.31B 4.35
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
139.02 23.75B 15.50B 1.33B 2.16B 7.34

Quest Diagnostics Inc Stock (DGX) Upgrades & Downgrades

Date Action Analyst Rating Change
Apr-02-25 Initiated Redburn Atlantic Buy
Mar-04-25 Downgrade Citigroup Buy → Neutral
Jan-06-25 Upgrade Leerink Partners Market Perform → Outperform
Dec-17-24 Upgrade Morgan Stanley Equal-Weight → Overweight
Dec-10-24 Resumed Jefferies Buy
Oct-23-24 Upgrade Robert W. Baird Neutral → Outperform
Aug-28-24 Resumed Evercore ISI In-line
Jul-10-24 Upgrade Citigroup Neutral → Buy
Feb-26-24 Initiated Leerink Partners Market Perform
Feb-07-24 Upgrade Jefferies Hold → Buy
Jan-03-24 Initiated Barclays Equal Weight
Dec-12-23 Upgrade BofA Securities Neutral → Buy
Jun-29-23 Initiated Piper Sandler Neutral
May-02-23 Downgrade BofA Securities Buy → Neutral
Apr-03-23 Upgrade Citigroup Sell → Neutral
Jan-23-23 Initiated Evercore ISI In-line
Nov-17-22 Downgrade Citigroup Neutral → Sell
Aug-22-22 Resumed Morgan Stanley Equal-Weight
Apr-04-22 Downgrade Citigroup Buy → Neutral
Feb-23-22 Downgrade UBS Buy → Neutral
Feb-02-22 Downgrade Jefferies Buy → Hold
Jan-28-22 Downgrade Deutsche Bank Buy → Hold
May-04-21 Upgrade UBS Neutral → Buy
Mar-12-21 Downgrade Robert W. Baird Outperform → Neutral
Oct-21-20 Upgrade Argus Hold → Buy
Jul-29-20 Upgrade KeyBanc Capital Markets Sector Weight → Overweight
Jul-14-20 Upgrade BofA Securities Neutral → Buy
Jun-09-20 Upgrade Wells Fargo Underweight → Equal Weight
Jun-02-20 Upgrade Deutsche Bank Hold → Buy
Apr-28-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Apr-27-20 Upgrade Citigroup Neutral → Buy
Apr-27-20 Upgrade Wolfe Research Underperform → Peer Perform
Mar-27-20 Downgrade Morgan Stanley Overweight → Equal-Weight
Jan-08-20 Initiated Wells Fargo Underweight
Jan-07-20 Downgrade Barclays Overweight → Equal Weight
Dec-19-19 Upgrade BofA/Merrill Underperform → Neutral
Jul-15-19 Downgrade Goldman Neutral → Sell
Apr-02-19 Upgrade Jefferies Hold → Buy
Mar-18-19 Resumed Credit Suisse Neutral
Jan-31-19 Downgrade Argus Buy → Hold
Jan-17-19 Initiated UBS Neutral
Jan-03-19 Downgrade BofA/Merrill Neutral → Underperform
Dec-03-18 Downgrade BofA/Merrill Buy → Neutral
Nov-30-18 Downgrade Goldman Buy → Neutral
View All

Quest Diagnostics Inc Stock (DGX) Latest News

pulisher
May 27, 2025

Quest Diagnostics (DGX) Participates in Upcoming Oppenheimer Meeting | DGX Stock News - GuruFocus

May 27, 2025
pulisher
May 27, 2025

HOLX vs. DGX: Which Women's Health-Focused Stock Is the Better Pick? - The Globe and Mail

May 27, 2025
pulisher
May 23, 2025

Is Wall Street Bullish or Bearish on Quest Diagnostics Stock? - Inkl

May 23, 2025
pulisher
May 23, 2025

Is Wall Street Bullish Or Bearish On Quest Diagnostics Stock? - Barchart.com

May 23, 2025
pulisher
May 22, 2025

Quest Diagnostics' $4M Rest Break Settlement Gets Initial OK - Law360

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics (DGX) Announces Results of 2025 Annual Meeting of Stockholders - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Quest Diagnostics Inc (DGX) Shares Gap Down to $171.44 on May 21 - GuruFocus

May 22, 2025
pulisher
May 21, 2025

What's Driving Quest Diagnostics Stock's 25.6% Rally in a Year? - Yahoo Finance

May 21, 2025
pulisher
May 20, 2025

Quest Diagnostics stock hits all-time high of $179.37 By Investing.com - Investing.com Nigeria

May 20, 2025
pulisher
May 19, 2025

Director Diaz Luis was granted 1,203 shares, increasing direct ownership by 42% to 4,054 units (SEC Form 4) - Quantisnow

May 19, 2025
pulisher
May 16, 2025

Quest Diagnostics to Speak at the William Blair 45th Annual Growth Stock Conference - PR Newswire

May 16, 2025
pulisher
May 16, 2025

Lung Cancer Diagnostics Market Outlook: Opportunities in Early - openPR.com

May 16, 2025
pulisher
May 16, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Momentum Stock - Yahoo Finance

May 16, 2025
pulisher
May 16, 2025

Quest Diagnostics CEO Reveals Future Growth Strategy: Key Insights Coming at William Blair Conference - Stock Titan

May 16, 2025
pulisher
May 15, 2025

Here's Why Quest Diagnostics (DGX) is a Strong Value Stock - Yahoo Finance

May 15, 2025
pulisher
May 15, 2025

Insider Sell: Mark Delaney Sells Shares of Quest Diagnostics Inc (DGX) - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics Keeps Dividend at $0.80 per Share, Payable July 21 to Shareholders as of July 7 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Quest Diagnostics (DGX) Declares Consistent Dividend - GuruFocus

May 15, 2025
pulisher
May 14, 2025

Quest Diagnostics Declares Quarterly Cash Dividend, Payable on July 21, 2025 - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

Quest Diagnostics : Forbes Names Quest Diagnostics One of America's Best Large Employers - marketscreener.com

May 14, 2025
pulisher
May 13, 2025

Is Quest Diagnostics Incorporated's (NYSE:DGX) Recent Stock Performance Influenced By Its Fundamentals In Any Way? - Yahoo

May 13, 2025
pulisher
May 13, 2025

Should You Continue to Retain DGX Stock in Your Portfolio? - TradingView

May 13, 2025
pulisher
May 13, 2025

Oncologists Report Seeing More Advanced Cancers and Say Current Tests Are Not Catching Cancer Recurrence Early Enough, New Quest Diagnostics Report Finds - PR Newswire

May 13, 2025
pulisher
May 08, 2025

Global Immunodiagnostics Market to Cross the USD 32 Billion by 2032 | DelveInsight - GlobeNewswire Inc.

May 08, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Sees Raised Target Price by JP Morgan | - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Nike To $70? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga

May 06, 2025
pulisher
May 06, 2025

Quest Diagnostics (DGX) Receives Price Target Increase from JPMo - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Take the Zacks Approach to Beat the Markets: ADMA Biologics, Limbach, Quest Diagnostics in Focus - MSN

May 06, 2025
pulisher
May 03, 2025

Quest Diagnostics Stock: A Leader But Waiting For Better Price (NYSE:DGX) - Seeking Alpha

May 03, 2025
pulisher
May 02, 2025

Quest Settles Fired Black Phlebotomist's Retaliation Suit - Law360

May 02, 2025
pulisher
May 01, 2025

Bullish on Quest Diagnosis Inc. - The Globe and Mail

May 01, 2025
pulisher
Apr 30, 2025

This Company Extended Its Post-Earnings Rally to Record Highs - The Globe and Mail

Apr 30, 2025
pulisher
Apr 29, 2025

Labcorp beats quarterly profit estimate on diagnostic test demand - Reuters

Apr 29, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook By Investing.com - Investing.com Canada

Apr 28, 2025
pulisher
Apr 28, 2025

Fitch elevates Quest Diagnostics’ rating to ’BBB+’ with stable outlook - Investing.com

Apr 28, 2025
pulisher
Apr 28, 2025

Piper Sandler Adjusts Price Target on Quest Diagnostics to $200 From $180, Maintains Neutral Rating - marketscreener.com

Apr 28, 2025
pulisher
Apr 26, 2025

Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight - GuruFocus

Apr 26, 2025
pulisher
Apr 24, 2025

Here's How Much You Would Have Made Owning Quest Diagnostics Stock In The Last 5 Years - Benzinga

Apr 24, 2025
pulisher
Apr 24, 2025

Truist Financial Keeps Their Hold Rating on Quest Diagnostics (DGX) - The Globe and Mail

Apr 24, 2025
pulisher
Apr 23, 2025

These Analysts Boost Their Forecasts On Quest Diagnostics After Better-Than-Expected Q1 Earnings - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

Morgan Stanley Adjusts Quest Diagnostics Price Target to $182 From $172, Maintains Overweight Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Baird Adjusts Quest Diagnostics Price Target to $194 From $191, Maintains Outperform Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Jefferies Adjusts Quest Diagnostics Price Target to $195 From $190, Maintains Buy Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Increase Following Str - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

Mizuho Securities Adjusts Quest Diagnostics Price Target to $190 From $189 - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Increase Following Strong Q1 Results | DGX Stock News - GuruFocus

Apr 23, 2025
pulisher
Apr 23, 2025

A Glimpse Into The Expert Outlook On Quest Diagnostics Through 12 Analysts - Benzinga

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics Incorporated (NYSE:DGX) Q1 2025 Earnings Call Transcript - Insider Monkey

Apr 23, 2025
pulisher
Apr 23, 2025

Truist Raises Price Target on Quest Diagnostics to $190 From $182, Keeps Hold Rating - marketscreener.com

Apr 23, 2025
pulisher
Apr 23, 2025

Quest Diagnostics (DGX) Sees Price Target Boost from Barclays | - GuruFocus

Apr 23, 2025

Quest Diagnostics Inc Stock (DGX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
diagnostics_research LH
$247.69
price up icon 2.13%
diagnostics_research WAT
$358.36
price up icon 3.46%
$157.16
price up icon 2.50%
diagnostics_research MTD
$1,162.84
price up icon 4.37%
diagnostics_research IQV
$140.54
price up icon 2.58%
Cap:     |  Volume (24h):